Companion Diagnostics Market Expansion Backed by Targeted Cancer Therapy Developments | Key Players: Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc.

The Companion Diagnostics market landscape is undergoing a transformative shift, driven by rapid technological advancements, evolving consumer behaviors, and intensifying competition across industries. This comprehensive market research report delivers in-depth insights, growth projections, and strategic analysis across key segments, empowering stakeholders with data-driven intelligence. Leveraging advanced analytics, trend forecasting, and competitive benchmarking, the report uncovers critical developments in innovation, emerging technologies, supply chain dynamics, and regulatory frameworks. Whether you're exploring investment opportunities, product development strategies, or expansion into high-growth regions, this report serves as your essential guide to navigating today's dynamic market environment.

Get exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/companion-diagnostics-market?ophp

Companion Diagnostics Market Growth

The global companion diagnostics market reached US$ 6.1 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 15.0 billion by 2030. The global companion diagnostics market is expected to exhibit a CAGR of 12.2% during the forecast Period.

Comprehensive Insight into Companion Diagnostics Market Landscape and Growth Trends:

Companion diagnostics are tests that predict a patient's response to specific drugs, especially in oncology. The market is advancing as precision medicine gains traction, with rising co-development of therapies and diagnostics fueling innovation.

Major Players Shaping the Competitive Landscape:

F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., Abbott Laboratories, Inc., Biomerieux SA, Siemens Healthcare, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter Inc.), Guardant Health and Illumina Inc and others.

Important Mergers, Acquisitions, and Market Shifts:

✅ In early 2025, Qiagen acquired Cellestis Limited for US$374 million, integrating QuantiFERON testing into its portfolio. This expansion supports its precision medicine focus and entry into infectious disease diagnostics

✅ In May 2025, LabCorp began offering Qiagen's therascreen FGFR mutation test to support J&J's Balversa treatment for urothelial cancer. This partnership increases diagnostic access in specialty cancer clinics

✅ In March 2024, Thermo Fisher teamed up with Bayer to co-develop NGS-based companion diagnostic assays using its Genexus Dx platform. This collaboration enables rapid patient stratification for Bayer's precision cancer therapies

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/companion-diagnostics-market?ophp

Methodology and Scope:

This Companion Diagnostics Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Companion Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Companion Diagnostics market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Companion Diagnostics industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Companion Diagnostics market?

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=companion-diagnostics-market?ophp

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.